New Issue: Orbital Catastrophe Ahead? Read Now

Vials of Smallpox Virus Found Unsecured at NIH

Sixty-year-old ampoule contains smallpox DNA, and it is unclear whether the virus is viable.

Join Our Community of Science Lovers!

Smallpox, officially preserved in two repositories worldwide, may have been sitting alive and well in an unsecured US government refrigerator. On July 8, the US Centers for Disease Control and Prevention (CDC) announced that vials containing the deadly virus had been discovered in a cardboard box in the refrigerator, located on the National Institutes of Health (NIH) campus in Bethesda, Maryland.

That refrigerator belongs to the US Food and Drug Administration (FDA), which has conducted some of its research at the Bethesda site since 1972. On July 1, FDA researchers discovered the vials — labelled "variola”, the name of the virus that causes smallpox — while conducting an inventory of the lab in preparation for a move to the FDA's headquarters in White Oak, Maryland. NIH safety officials determined that the virus had not leaked and there was no danger to the employees who had found it, and then sequestered the samples in a secure lab on campus, the agency said.

The NIH and the FDA then reported the find to the CDC and the World Health Organization (WHO), and on July 7, CDC employees flew the vials to Atlanta, Georgia, where researchers confirmed the presence of variola DNA. They are now attempting to grow the virus in cell culture to determine whether it is still viable, and expect results in two weeks. The NIH believes that the box that held the smallpox vials dates back to the 1950s, but the virus is extremely stable in its powdered form and could still be infectious.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Since its eradication in 1980, smallpox officially exists in only two places: the CDC in Atlanta, and its Russian counterpart, the State Research Center of Virology and Biotechnology VECTOR, in Novosibirsk. But most experts believe that numerous stocks exist around the world, whether in clandestine labs or preserved in tissue, such as the scabs used for immunizations into the 20th century. A similarly forgotten stock of smallpox was found in a lab in eastern Europe in the 1990s, for instance, and more recently at the Swiss Serum and Vaccine Institute in Bern, says Peter Jahrling, a virologist at the National Institute of Allergy and Infectious Diseases in Frederick, Maryland. “Virologists are pack rats,” he says.

And those are only the ones that officials know about: Jahrling says that he found out about the NIH discovery when White House officials were discussing how to notify the WHO. He says that in the past, the response to such finds was likely to simply autoclave the virus to kill it.

“This points out the concern that folks have articulated all over the world, that there is the possibility of undisclosed stocks,” says virologist Inger Damon, who heads the CDC's smallpox research. But the case is unusual, Damon says, because the vials were stored in a cold unit instead of a liquid nitrogen freezer as the official stocks are.

The NIH says that it plans to conduct a comprehensive search of all its laboratory spaces as soon as possible. But such a move may not be sufficient to find other forgotten stocks, if they exist, says Jahrling, as disorganized scientists could have squirrelled samples away in unexpected places decades ago. “You could lock down and count every ampoule and still not find it,” he says.

This article is reproduced with permission and was first published on July 9, 2014.

Sara Reardon is a freelance biomedical journalist based in Bozeman, Mont. She is a former staff reporter at Nature, New Scientist and Science and has a master’s degree in molecular biology.

More by Sara Reardon

First published in 1869, Nature is the world's leading multidisciplinary science journal. Nature publishes the finest peer-reviewed research that drives ground-breaking discovery, and is read by thought-leaders and decision-makers around the world.

More by Nature magazine

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe